4//SEC Filing
Goldberg Zelanna 4
Accession 0001626199-21-000083
CIK 0001626199other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 6:16 PM ET
Size
5.8 KB
Accession
0001626199-21-000083
Insider Transaction Report
Form 4
Goldberg Zelanna
Chief Medical Officer
Transactions
- Award
Stock Option (Right to buy)
2021-06-01+160,000→ 160,000 totalExercise: $10.29Exp: 2031-05-31→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest and become exercisable on 6/1/2022 (the "Vesting Commencement Date") and 1/48th of the shares subject to the option shall vest monthly thereafter on thesame day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider through eachsuch date.
Documents
Issuer
ALPINE IMMUNE SCIENCES, INC.
CIK 0001626199
Entity typeother
Related Parties
1- filerCIK 0001861993
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 6:16 PM ET
- Size
- 5.8 KB